Maharashtra FDA Issues Urgent Warning Against Coldrif Syrup After Child Deaths
Maharashtra FDA bans Coldrif Syrup Batch SR-13 after child fatalities linked to toxic contamination; public urged to avoid use immediately.
Pune, October 06, 2025: The Maharashtra Food and Drug Administration (FDA) has issued an urgent statewide warning and ban on the sale, distribution, and use of Coldrif Syrup Batch No. SR-13 after reports of multiple child deaths in other states. The syrup, manufactured by a pharmaceutical company in Tamil Nadu, was found to be contaminated with diethylene glycol (DEG), a toxic chemical known to cause kidney failure and other severe health complications.
The FDA directive, issued on October 5, 2025, instructs all pharmacies, distributors, and individuals in possession of this batch to immediately report it to local authorities. The move aims to prevent further tragedies and protect children from exposure to the toxic substance.
This action comes after a series of fatal incidents where at least 18 children lost their lives after consuming contaminated cough syrups in neighboring states. In response, health authorities have ordered rigorous testing of cough syrup samples and reinforced stricter regulations for the production, sale, and monitoring of pharmaceutical products containing high-risk ingredients.
Parents and caregivers are strongly advised to avoid purchasing or using Coldrif Syrup Batch SR-13 and to consult qualified healthcare professionals for safe alternatives. Authorities also urge anyone who has administered the syrup to a child to watch for symptoms such as nausea, vomiting, lethargy, or kidney-related issues and to report any adverse reactions immediately.
The incident underscores the critical need for enhanced drug safety monitoring, careful inspection of pharmaceutical manufacturing practices, and public vigilance in selecting medicines for children. By adhering to FDA advisories and reporting unsafe products, the public can help prevent further loss of life and ensure safer access to essential medications.
Follow us On Our Social media Handles :
Instagram
Youtube
Facebook
Twitter
